Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Secretome of Hypoxia-Mesenchymal Stem Cells in Improving Survival of Severe Covid-19 Patients

NCT04753476 is registered in ClinicalTrials.gov with Stem Cell and Cancer Research Indonesia as lead sponsor.

NCT NCT04753476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04753476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Secretome of Hypoxia-Mesenchymal Stem Cells in Improving Survival of Severe Covid-19 Patients
Lead sponsor
Stem Cell and Cancer Research Indonesia
Phase
Phase 2
Overall status
Unknown status
Start date
June 8, 2020
Completion date
March 1, 2022
Enrollment
48 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, cytokine storm